BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27739133)

  • 21. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
    Chung J; An SH; Kang SW; Kwon K
    PLoS One; 2016; 11(1):e0147839. PubMed ID: 26807573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oleate blocks palmitate-induced abnormal lipid distribution, endoplasmic reticulum expansion and stress, and insulin resistance in skeletal muscle.
    Peng G; Li L; Liu Y; Pu J; Zhang S; Yu J; Zhao J; Liu P
    Endocrinology; 2011 Jun; 152(6):2206-18. PubMed ID: 21505048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
    Zaccardi F; Pitocco D; Caputo S; Ghirlanda G
    Diabet Med; 2011 Jan; 28(1):126; author reply 127-8. PubMed ID: 21166858
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: diabetes and atherosclerosis--running on a common road.
    Federici M; Lauro R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes.
    Jeong YT; Kim YD; Jung YM; Park DC; Lee DS; Ku SK; Li X; Lu Y; Chao GH; Kim KJ; Lee JY; Baek MC; Kang W; Hwang SL; Chang HW
    Mol Pharmacol; 2013 Jul; 84(1):147-57. PubMed ID: 23658008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular Mechanisms of Insulin Resistance: An Update].
    GutiƩrrez-Rodelo C; Roura-Guiberna A; Olivares-Reyes JA
    Gac Med Mex; 2017; 153(2):214-228. PubMed ID: 28474708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin says NO to cardiovascular disease.
    Yu Q; Gao F; Ma XL
    Cardiovasc Res; 2011 Feb; 89(3):516-24. PubMed ID: 21051417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoplasmic reticulum stress and inflammation in obesity and type 2 diabetes.
    Hotamisligil GS
    Novartis Found Symp; 2007; 286():86-94; discussion 94-8, 162-3, 196-203. PubMed ID: 18269176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role for endoplasmic reticulum stress in diabetes mellitus.
    Eizirik DL; Cardozo AK; Cnop M
    Endocr Rev; 2008 Feb; 29(1):42-61. PubMed ID: 18048764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of hypertension in diabetes.
    Stas SN; El-Atat FA; Sowers JR
    Rev Endocr Metab Disord; 2004 Aug; 5(3):221-5. PubMed ID: 15211093
    [No Abstract]   [Full Text] [Related]  

  • 35. A natural compound jaceosidin ameliorates endoplasmic reticulum stress and insulin resistance via upregulation of SERCA2b.
    Ouyang Z; Li W; Meng Q; Zhang Q; Wang X; Elgehama A; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Biomed Pharmacother; 2017 May; 89():1286-1296. PubMed ID: 28320096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoplasmic reticulum as a therapeutic target in type 2 diabetes: Role of phytochemicals.
    Sajadimajd S; Deravi N; Forouhar K; Rahimi R; Kheirandish A; Bahramsoltani R
    Int Immunopharmacol; 2023 Jan; 114():109508. PubMed ID: 36495694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes.
    Zhang N; Cao MM; Liu H; Xie GY; Li YB
    J Physiol Biochem; 2015 Jun; 71(2):319-27. PubMed ID: 25632827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review.
    Sozen E; Ozer NK
    Redox Biol; 2017 Aug; 12():456-461. PubMed ID: 28319895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3.
    Robertson LA; Kim AJ; Werstuck GH
    Can J Physiol Pharmacol; 2006 Jan; 84(1):39-48. PubMed ID: 16845889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-dependent insulin resistance in hepatocytes: mathematical model.
    Dokukina IV; Yamashev MV; Samarina EA; Tilinova OM; Grachev EA
    J Theor Biol; 2021 Aug; 522():110684. PubMed ID: 33794287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.